Page last updated: 2024-11-04

terfenadine and HIV Infections

terfenadine has been researched along with HIV Infections in 2 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, D1
Fang, Z1
Huang, B1
Lu, X1
Zhang, H1
Xu, H1
Huo, Z1
Zhou, Z1
Yu, Z1
Meng, Q1
Wu, G1
Ding, X1
Tian, Y1
Daelemans, D1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Liu, X1
Nightingale, SL1

Other Studies

2 other studies available for terfenadine and HIV Infections

ArticleYear
Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.
    Journal of medicinal chemistry, 2017, 05-25, Volume: 60, Issue:10

    Topics: Animals; Anti-HIV Agents; Drug Resistance, Viral; HEK293 Cells; HIV Infections; HIV Reverse Transcri

2017
From the Food and Drug Administration.
    JAMA, 1992, Aug-12, Volume: 268, Issue:6

    Topics: Astemizole; Contraindications; Drug Therapy, Combination; HIV Infections; Humans; Terfenadine; Unite

1992